Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2000

01-12-2000 | Paper Report

Nuclear cytometric changes in breast carcinogenesis

Author: Syed Mohsin

Published in: Breast Cancer Research | Issue 1/2000

Login to get access

Excerpt

Image morphometry has been shown to provide useful information in several types of human tumors, including breast. Image cytometry can identify preinvasive lesions in human cervix with malignant potential and may predict response in patients with prostate and renal carcinoma. In breast cancer, it has been shown that morphometric data correlates with several important biological factors, including hormone receptors and p53 status. However, premalignant mammary lesions have not been studied in a systematic fashion using this technique. …
Literature
1.
Mommers ECM, Poulin N, Sangulin J, Meijer CJLM, Baak JPA, van Diest PJ: Nuclear cytometric changes in breast carcinogenesis. J Pathol. 2000, In Press: 4592-4603.
Metadata
Title
Nuclear cytometric changes in breast carcinogenesis
Author
Syed Mohsin
Publication date
01-12-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr-2000-66716

Other articles of this Issue 1/2000

Breast Cancer Research 1/2000 Go to the issue

Paper Report

Duration of adjuvant tamoxifen treatment

Paper Report

HOXA5 regulation of p53 in breast tumours

Paper Report

Comparison of different methods of HER-2 analysis in archival tissue

Paper Report

Enhanced activity of anti-Lewisyhumanised 3S193 when combined with Taxol

Paper Report

Chromosome 6 alterations

Paper Report

Tamoxifen, angiogenesis, oestrogens and animal models
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits